J Gynecol Oncol.  2013 Jan;24(1):7-13. 10.3802/jgo.2013.24.1.7.

Knowledge about HPV, relation between HPV and cervix cancer and acceptance of HPV vaccine in women in eastern region of Turkey

• Tonguc E
• Gungor T
• Var T
• Kavak E
• Yucel M
• Uzunlar O

• KMID: 2288555
• DOI: http://doi.org/10.3802/jgo.2013.24.1.7

Abstract

OBJECTIVE
The aim of this study is to determine the knowledge of the women living in the eastern region of Turkey about human papillomavirus (HPV) and cervix cancer and their approaches to HPV vaccine.
METHODS
The questionnaire forms were distributed to 1,052 patients who applied to the Gynecology Department of Elazig Training and Research Hospital. The subjects were recruited from the general gynecology outpatient clinic of the hospital. The patients from sexually transmitted disease and oncology outpatient clinics were not included in the study. The information about 945 women who completely filled in the questionnaire form was included into the study. The questions set forth in the questionnaire form consisting of 20 questions were prepared by taking the studies previously performed as model.
RESULTS
Ninety-five percent of the women were married and 83.5% were housewives (unemployed). Thirteen percent of the women were illiterate, only 12% were graduated from university. Seventy-four percent of the women did not hear about HPV, 78.4% did not know about HPV vaccine, 63% did not know about the fact that some viruses cause cancer, and 83% did not know about the relation between HPV and cervix cancer. According to the multivariate analysis, free-of-charge vaccination, vaccinated relatives or friends, graduation from university and being under the age of 25 predict to accept the vaccine for themselves.
CONCLUSION
The young population and the women who graduated from university seem to be more well-informed about HPV and more sensitive about being vaccinated. In addition, free vaccination will ensure the expansion of the vaccine.

Keyword

Human papillomavirus; Papillomavirus vaccine; Uterine cervical neoplasms

MeSH Terms

Ambulatory Care Facilities
Cervix Uteri
Dietary Sucrose
Female
Friends
Gynecology
Humans
Multivariate Analysis
Sexually Transmitted Diseases
Turkey
Uterine Cervical Neoplasms
Vaccination
Surveys and Questionnaires
Dietary Sucrose

Reference

1. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003. 16:1–17.

2. Cates W Jr. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States: American Social Health Association Panel. Sex Transm Dis. 1999. 26:S2–S7.

3. Harro CD, Pang YY, Roden RB, Hildesheim A, Wang Z, Reynolds MJ, et al. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J Natl Cancer Inst. 2001. 93:284–292.

4. Jin XW, Cash J, Kennedy AW. Human papillomavirus typing and the reduction of cervical cancer risk. Cleve Clin J Med. 1999. 66:533–539.

5. Tuncer M. Cancer control in Turkey. 2008. Ankara: Ministry of Health Publication.

6. Inal MM, Kose S, Yildirim Y, Ozdemir Y, Toz E, Ertopcu K, et al. The relationship between human papillomavirus infection and cervical intraepithelial neoplasia in Turkish women. Int J Gynecol Cancer. 2007. 17:1266–1270.

7. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER, et al. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007. 56:1–24.

8. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med. 1997. 102:3–8.

9. Slomovitz BM, Sun CC, Frumovitz M, Soliman PT, Schmeler KM, Pearson HC, et al. Are women ready for the HPV vaccine? Gynecol Oncol. 2006. 103:151–154.

10. Dursun P, Altuntas B, Kuscu E, Ayhan A. Women's knowledge about human papillomavirus and their acceptance of HPV vaccine. Aust N Z J Obstet Gynaecol. 2009. 49:202–206.

11. Donders GG, Gabrovska M, Bellen G, Van Keirsbilck J, Van Den Bosch T, Riphagen I, et al. Knowledge of cervix cancer, human papilloma virus (HPV) and HPV vaccination at the moment of introduction of the vaccine in women in Belgium. Arch Gynecol Obstet. 2008. 277:291–298.

12. Giles M, Garland S. A study of women's knowledge regarding human papillomavirus infection, cervical cancer and human papillomavirus vaccines. Aust N Z J Obstet Gynaecol. 2006. 46:311–315.

13. Oren A, Skjeldestad FE. Little knowledge about human papillomavirus among young Norwegian women. Tidsskr Nor Laegeforen. 2006. 126:2101–2103.

14. Moreira ED Jr, Oliveira BG, Ferraz FM, Costa S, Costa Filho JO, Karic G. Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention. Int J Gynecol Cancer. 2006. 16:599–603.

15. Baykal C, Al A, Ugur MG, Cetinkaya N, Attar R, Arioglu P. Knowledge and interest of Turkish women about cervical cancer and HPV vaccine. Eur J Gynaecol Oncol. 2008. 29:76–79.

16. Tiro JA, Meissner HI, Kobrin S, Chollette V. What do women in the U.S. know about human papillomavirus and cervical cancer? Cancer Epidemiol Biomarkers Prev. 2007. 16:288–294.

17. Dempsey AF, Zimet GD, Davis RL, Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics. 2006. 117:1486–1493.

18. Massad LS, Verhulst SJ, Hagemeyer M, Brady P. Knowledge of the cervical cancer screening process among rural and urban illinois women undergoing colposcopy. J Low Genit Tract Dis. 2006. 10:252–255.

19. Weisberg E, Bateson D, McCaffery K, Skinner SR. HPV vaccination catch up program: utilisation by young Australian women. Aust Fam Physician. 2009. 38:72–76.

20. Kwan TT, Chan KK, Yip AM, Tam KF, Cheung AN, Lo SS, et al. Acceptability of human papillomavirus vaccination among Chinese women: concerns and implications. BJOG. 2009. 116:501–510.

21. Oh H. Knowledge about HPV, and the attitudes toward HPV vaccination among adult women in Asian countries: a literature review. J Korean Oncol Nurs. 2011. 11:171–178.

22. Di Giuseppe G, Abbate R, Liguori G, Albano L, Angelillo IF. Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. Br J Cancer. 2008. 99:225–229.

23. Pelucchi C, Esposito S, Galeone C, Semino M, Sabatini C, Picciolli I, et al. Knowledge of human papillomavirus infection and its prevention among adolescents and parents in the greater Milan area, Northern Italy. BMC Public Health. 2010. 10:378.

24. Perkins RB, Langrish SM, Stern LJ, Burgess JF, Simon CJ. Impact of patient adherence and test performance on the cost-effectiveness of cervical cancer screening in developing countries: the case of Honduras. Womens Health Issues. 2010. 20:35–42.

25. Litton AG, Desmond RA, Gilliland J, Huh WK, Franklin FA. Factors associated with intention to vaccinate a daughter against HPV: a statewide survey in Alabama. J Pediatr Adolesc Gynecol. 2011. 24:166–171.

26. DiAngi YT, Panozzo CA, Ramogola-Masire D, Steenhoff AP, Brewer NT. A cross-sectional study of HPV vaccine acceptability in Gaborone, Botswana. PLoS One. 2011. 6:e25481.

27. Do YK, Wong KY. Awareness and acceptability of human papillomavirus vaccine: an application of the instrumental variables bivariate probit model. BMC Public Health. 2012. 12:31.

28. Becker-Dreps S, Otieno WA, Brewer NT, Agot K, Smith JS. HPV vaccine acceptability among Kenyan women. Vaccine. 2010. 28:4864–4867.

29. Sauvageau C, Duval B, Gilca V, Lavoie F, Ouakki M. Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada. BMC Public Health. 2007. 7:304.

30. Manhart LE, Burgess-Hull AJ, Fleming CB, Bailey JA, Haggerty KP, Catalano RF. HPV vaccination among a community sample of young adult women. Vaccine. 2011. 29:5238–5244.